SK16522000A3 - Forma 1-(6-chlórnaft-2-ylsulfonyl)-4-[4-(4- -pirydyl)benzoyl]piperazínu so zmenšenou veľkosťou častíc, farmaceutická kompozícia obsahujúca túto formu a jej použitie - Google Patents
Forma 1-(6-chlórnaft-2-ylsulfonyl)-4-[4-(4- -pirydyl)benzoyl]piperazínu so zmenšenou veľkosťou častíc, farmaceutická kompozícia obsahujúca túto formu a jej použitie Download PDFInfo
- Publication number
- SK16522000A3 SK16522000A3 SK1652-2000A SK16522000A SK16522000A3 SK 16522000 A3 SK16522000 A3 SK 16522000A3 SK 16522000 A SK16522000 A SK 16522000A SK 16522000 A3 SK16522000 A3 SK 16522000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- chloronaphth
- benzoyl
- piperazine
- compound
- pyridyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809350.3A GB9809350D0 (en) | 1998-05-02 | 1998-05-02 | Novel salt |
| PCT/GB1999/001316 WO1999057112A1 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK16522000A3 true SK16522000A3 (sk) | 2001-05-10 |
Family
ID=10831311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1652-2000A SK16522000A3 (sk) | 1998-05-02 | 1999-04-27 | Forma 1-(6-chlórnaft-2-ylsulfonyl)-4-[4-(4- -pirydyl)benzoyl]piperazínu so zmenšenou veľkosťou častíc, farmaceutická kompozícia obsahujúca túto formu a jej použitie |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1084118A1 (ja) |
| JP (1) | JP2002513789A (ja) |
| KR (1) | KR20010043216A (ja) |
| CN (1) | CN1308629A (ja) |
| AU (1) | AU3719699A (ja) |
| BR (1) | BR9910176A (ja) |
| CA (1) | CA2331041A1 (ja) |
| EE (1) | EE200000638A (ja) |
| GB (1) | GB9809350D0 (ja) |
| HU (1) | HUP0102394A3 (ja) |
| IL (1) | IL139405A0 (ja) |
| NO (1) | NO20005498D0 (ja) |
| PL (1) | PL343705A1 (ja) |
| SK (1) | SK16522000A3 (ja) |
| WO (1) | WO1999057112A1 (ja) |
| ZA (1) | ZA200006036B (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69833036T2 (de) * | 1997-09-30 | 2006-06-22 | Daiichi Pharmaceutical Co., Ltd. | Sulfonylderivate |
| TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| WO2003000657A1 (fr) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
| DK1569912T3 (en) | 2002-12-03 | 2015-06-29 | Pharmacyclics Inc | 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA56197C2 (uk) * | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
| ATE334975T1 (de) * | 1997-05-30 | 2006-08-15 | Takeda Pharmaceutical | Sulfonamidderivate, ihre herstellung und verwendung |
| DE69833036T2 (de) * | 1997-09-30 | 2006-06-22 | Daiichi Pharmaceutical Co., Ltd. | Sulfonylderivate |
-
1998
- 1998-05-02 GB GBGB9809350.3A patent/GB9809350D0/en not_active Ceased
-
1999
- 1999-04-27 EE EEP200000638A patent/EE200000638A/xx unknown
- 1999-04-27 PL PL99343705A patent/PL343705A1/xx not_active Application Discontinuation
- 1999-04-27 WO PCT/GB1999/001316 patent/WO1999057112A1/en not_active Application Discontinuation
- 1999-04-27 KR KR1020007012149A patent/KR20010043216A/ko not_active Application Discontinuation
- 1999-04-27 BR BR9910176-9A patent/BR9910176A/pt not_active IP Right Cessation
- 1999-04-27 IL IL13940599A patent/IL139405A0/xx unknown
- 1999-04-27 SK SK1652-2000A patent/SK16522000A3/sk unknown
- 1999-04-27 CA CA002331041A patent/CA2331041A1/en not_active Abandoned
- 1999-04-27 EP EP99919395A patent/EP1084118A1/en not_active Withdrawn
- 1999-04-27 CN CN99808217A patent/CN1308629A/zh active Pending
- 1999-04-27 JP JP2000547082A patent/JP2002513789A/ja active Pending
- 1999-04-27 HU HU0102394A patent/HUP0102394A3/hu unknown
- 1999-04-27 AU AU37196/99A patent/AU3719699A/en not_active Abandoned
-
2000
- 2000-10-25 ZA ZA200006036A patent/ZA200006036B/en unknown
- 2000-11-01 NO NO20005498A patent/NO20005498D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999057112A1 (en) | 1999-11-11 |
| EE200000638A (et) | 2002-04-15 |
| HUP0102394A2 (hu) | 2001-12-28 |
| HUP0102394A3 (en) | 2003-01-28 |
| ZA200006036B (en) | 2002-01-25 |
| IL139405A0 (en) | 2001-11-25 |
| NO20005498L (no) | 2000-11-01 |
| JP2002513789A (ja) | 2002-05-14 |
| BR9910176A (pt) | 2001-01-09 |
| GB9809350D0 (en) | 1998-07-01 |
| NO20005498D0 (no) | 2000-11-01 |
| CN1308629A (zh) | 2001-08-15 |
| CA2331041A1 (en) | 1999-11-11 |
| EP1084118A1 (en) | 2001-03-21 |
| KR20010043216A (ko) | 2001-05-25 |
| AU3719699A (en) | 1999-11-23 |
| PL343705A1 (en) | 2001-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2067975C1 (ru) | 1,2-дигидро-2-оксопиридины, их физиологически приемлемые соли и фармацевтическая композиция | |
| WO1998006433A1 (fr) | MEDICAMENTS COMPRENANT UN INHIBITEUR DE LA Rho KINASE | |
| BG102948A (bg) | Пиразинони като инхибитори на тромбин | |
| CN103119030A (zh) | 基质金属蛋白酶抑制剂 | |
| US20110045065A1 (en) | Substance having antioxidant, geroprotective and anti-ischemic activity and method for the preparation thereof | |
| TW200402416A (en) | Novel piperidine derivatives | |
| EP2138482A1 (en) | Bicyclic heterocyclic compound | |
| EP0562599A1 (en) | Condensed thiadiazole derivative, method of its production, and use thereof | |
| JP2002525370A (ja) | トロンビン阻害剤 | |
| EP1153014B1 (de) | Beta-alaninderivate | |
| US6326386B1 (en) | Benzamide derivatives as thrombin inhibitors | |
| JP4248245B2 (ja) | ６−フェニルベンゾナフチリジン | |
| JPH093066A (ja) | クロモン誘導体 | |
| DE19713000A1 (de) | Adhäsionsrezeptor-Antagonisten | |
| JPWO2003011812A1 (ja) | ヒト−β−トリプターゼ阻害活性を有する新規アミン誘導体およびそれを含有する医薬 | |
| SK16522000A3 (sk) | Forma 1-(6-chlórnaft-2-ylsulfonyl)-4-[4-(4- -pirydyl)benzoyl]piperazínu so zmenšenou veľkosťou častíc, farmaceutická kompozícia obsahujúca túto formu a jej použitie | |
| EP3068763B1 (en) | Hydrobromide salt of n-(4-chloro-2-hydroxy-3-((3s)-3-piperidinylsulfonyl)phenyl)-n'-(3-fluoro-2-methylphenyl)urea | |
| JP2007532626A (ja) | Ｈｉｖ治療用硫黄連結イミダゾール化合物 | |
| TWI257389B (en) | Pharmaceutical compound | |
| US7674792B2 (en) | 5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one | |
| WO2001017990A1 (en) | Heterocyclic derivatives as inhibitors of factor xa | |
| US20080194635A1 (en) | Crystalline Forms of Cis-5-Fluoro-N-[4-(2-Hydroxy-4-Methylbenzamido) Cyclohexyl]-2-(Tetrahydrothiopyran-4-Yloxy) Nicotinamide | |
| CZ20004037A3 (cs) | Forma l-(6-chlornaft-2-ylsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazinu se zmenšenu velikostí částic a farmaceutická kompozice tuto formu obsahující | |
| JP3457281B2 (ja) | トロンビン阻害剤としてのベンズアミド誘導体 | |
| MXPA00010676A (en) | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl]piperazine |